Bailly, C.; Chalopin, B.; Gouard, S.; Carlier, T.; Remaud-Le Saëc, P.; Marionneau-Lambot, S.; Moreau, P.; Touzeau, C.; Kraeber-Bodere, F.; Bodet-Milin, C.;
et al. ImmunoPET in Multiple Myeloma—What? So What? Now What? Cancers 2020, 12, 1467.
https://doi.org/10.3390/cancers12061467
AMA Style
Bailly C, Chalopin B, Gouard S, Carlier T, Remaud-Le Saëc P, Marionneau-Lambot S, Moreau P, Touzeau C, Kraeber-Bodere F, Bodet-Milin C,
et al. ImmunoPET in Multiple Myeloma—What? So What? Now What? Cancers. 2020; 12(6):1467.
https://doi.org/10.3390/cancers12061467
Chicago/Turabian Style
Bailly, Clément, Benjamin Chalopin, Sébastien Gouard, Thomas Carlier, Patricia Remaud-Le Saëc, Séverine Marionneau-Lambot, Philippe Moreau, Cyrille Touzeau, Françoise Kraeber-Bodere, Caroline Bodet-Milin,
and et al. 2020. "ImmunoPET in Multiple Myeloma—What? So What? Now What?" Cancers 12, no. 6: 1467.
https://doi.org/10.3390/cancers12061467
APA Style
Bailly, C., Chalopin, B., Gouard, S., Carlier, T., Remaud-Le Saëc, P., Marionneau-Lambot, S., Moreau, P., Touzeau, C., Kraeber-Bodere, F., Bodet-Milin, C., & Chérel, M.
(2020). ImmunoPET in Multiple Myeloma—What? So What? Now What? Cancers, 12(6), 1467.
https://doi.org/10.3390/cancers12061467